Dufresne
almost there...
- Messages
- 1,039
- Location
- Laurentians, Quebec
So far neither myself or my sister have had any extreme/acute herxheimer reactions, nothing at least that would be suggestive of a major die-off of spirochetes. Did manage to see KDM before leaving to pose the cyst question, the reason he doesn't start with a Flagyl/Tindamax type antibiotic is due to the potentially severe herx reaction, he prefers to target the extra-cellular form initially. This decision is presumably based on a lot of clinical experience so is hard to argue against, but given that we have been on Doxy for some time I am finding it difficult to justify the delay. Would be interesting to know the kind of protocols other doctors that treat late-stage Lyme are using and how they incorporate the cyst-busters.
I believe doxy is effective against intracellular bugs, provided one's immune system is not too messed up and humorally dominant. Remember doxy is bacteriostatic, and if your immune system is not able to finish the job, all you're doing is stunning the buggers. I know Dr Horowitz tends to double up on his intracellular antibiotics.
A lot of people get a significant herx using samento and, as Dr Sapi has shown, it works as well as doxy on spirochetes while still hitting cysts and such. This has been my experience as well. I don't herx at all on high-dose doxy, but samento will get me for at least a few days into a new protocol.
Incidentally, I'm a huge Radiohead fan. I've seen them several times, front row and everything, despite this shitty disease.
Abstract
A tick-borne, multisystemic disease, Lyme borreliosis caused by the spirochete Borrelia burgdorferi has grown into a major public health problem during the last 10 years. The primary treatment for chronic Lyme disease is administration of various antibiotics. However, relapse often occurs when antibiotic treatment is discontinued. One possible explanation for this is that B. burgdorferi become resistant to antibiotic treatment, by converting from their vegetative spirochete form into different round bodies and/or into biofilmlike colonies. There is an urgent need to find novel therapeutic agents that can eliminate all these different morphologies of B. burgdorferi. In this study, two herbal extracts, Samento and Banderol, as well as doxycycline (one of the primary antibiotics for Lyme disease treatment) were tested for their in vitro effectiveness on several of the different morphological forms of B. burgdorferi (spirochetes, round bodies, and biofilmlike colonies) using fluorescent, darkfield microscopic, and BacLight viability staining methods. Our results demonstrated that both herbal agents, but not doxycycline, had very significant effects on all forms of B. burgdorferi, especially when used in combination, suggesting that herbal agents could provide an effective therapeutic approach for Lyme disease patients.